
Here, take a look at some of the most expensive and luxurious houses in India (and one in London) that…
PEL’s net profit before exceptional gains rose 369% to Rs 3,545 crore in Q3, compared with Rs755 crore a year…
It is one of the leading developers with 15 million square feet of residential and commercial under development in the…
The exit of the consortium, which was the highest bidder for RCap as a core investment company (CIC), comes a…
Over-valued offer, lock-in regulation likely reason
Meanwhile, the revenue from Operation grew by 11 percent to INR 3,202 Crore versus INR 2,889 Crore in H1FY22.
Under the new clause, the lenders can challenge any resolution plan as and when they want.
The company claims that the Report demonstrates PPL’s intent of sharing its sustainability performance and targets with its stakeholders.
The demerger follows the group’s acquisition of DHFL for Rs.34,250 crore, which was completed in September 2021.
Piramal Group chairman Ajay Piramal said the financial services arm is planning to expand the branch network further by adding…
The company had acquired DHFL for Rs 34,250 crore and is in process of demerger of the pharmaceuticals business by…
“The RBI has granted a certificate of registration to the company to commence the business of non-banking financial institution without…
Addressing shareholders in the company’s annual report for 2021-22, Piramal said the company’s pharma vertical is expected to have nearly…
According to the contours of the agreement, the pharmaceuticals business would be demerged from PEL and consolidated under Piramal Pharma.…
Two prospective bidders, Piramal Enterprise and IndusInd Bank, have sought extension of the deadline as they needed more time to…
Earlier in May, the CoC had extended the deadline to June 20 from the earlier May 26, following a poor…
A consortium led by Piramal Group is one of the eight serious contenders for acquiring RCap’s assets, from whom creditors…
The company will continue to make required investments in talent and technology. After the DHFL acquisition, Piramal plans to leverage…
The size of the issue is up to Rs 50 crore along with an option to retain over subscription of…
Consol. PAT expected to rise by 9% q-q in Q4; FY22-24e PAT raised by 1-3%; ‘Buy’ retained with TP of…
The debentures are proposed to be listed on debt segment and capital market segment of National Stock Exchange (NSE) and…
The pharmaceuticals vertical clocked a revenue of Rs 1,578.05 crore in the quarter. It was at Rs 1,373.64 crore in…
Loading…
Something went wrong. Please refresh the page and/or try again.